Vpr stimulates viral expression and induces cell killing in human immunodeficiency virus type 1-infected dividing Jurkat T cells. 1998

X J Yao, and A J Mouland, and R A Subbramanian, and J Forget, and N Rougeau, and D Bergeron, and E A Cohen
Laboratoire de rétrovirologie humaine, Département de microbiologie et immunologie, Faculté de médecine, Université de Montréal, Montréal, Québec, Canada H3C 3J7.

In this study we investigated the effects of Vpr during human immunodeficiency virus (HIV) infection of proliferating Jurkat T cells by using a vesicular stomatitis virus envelope G glycoprotein pseudotyped HIV superinfection system. We observe that the expression of Vpr results in a severe reduction in the life span of HIV type 1 (HIV-1)-infected dividing T cells in culture. In agreement with a recent report (S. A. Stewart, B. Poon, J. B. M. Jowett, and I. S. Chen, J. Virol. 71:5579-5592, 1997), we show that events characteristic of apoptotic cell death are involved in the Vpr-mediated cytopathic effects. Our results also show that infection with viruses expressing the wild-type vpr gene results in an increase in viral gene expression and production. Interestingly, the effects of Vpr on cell viability and on viral gene expression both correlate with the ability of the protein to induce a cell cycle arrest in the G2/M phase. Mutagenesis analyses show that the C terminus of Vpr is essential for these biological activities. Although the role of Vpr is currently associated with the infection of nondividing cells, our results suggest that Vpr can also directly increase viral replication in vivo in infected dividing T cells. Furthermore, these in vitro observations suggest that Vpr-mediated cytotoxic effects could contribute to the CD4+ depletion associated with AIDS progression.

UI MeSH Term Description Entries
D002453 Cell Cycle The complex series of phenomena, occurring between the end of one CELL DIVISION and the end of the next, by which cellular material is duplicated and then divided between two daughter cells. The cell cycle includes INTERPHASE, which includes G0 PHASE; G1 PHASE; S PHASE; and G2 PHASE, and CELL DIVISION PHASE. Cell Division Cycle,Cell Cycles,Cell Division Cycles,Cycle, Cell,Cycle, Cell Division,Cycles, Cell,Cycles, Cell Division,Division Cycle, Cell,Division Cycles, Cell
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014162 Transfection The uptake of naked or purified DNA by CELLS, usually meaning the process as it occurs in eukaryotic cells. It is analogous to bacterial transformation (TRANSFORMATION, BACTERIAL) and both are routinely employed in GENE TRANSFER TECHNIQUES. Transfections
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D016336 Gene Products, vpr Trans-acting proteins which accelerate retroviral virus replication. The vpr proteins act in trans to increase the levels of specified proteins. vpr is short for viral protein R, where R is undefined. vpr Gene Products,vpr Protein,Gene Product, vpr,Viral Protein R,Viral Protein R (vpr),Protein R, Viral,vpr Gene Product
D016923 Cell Death The termination of the cell's ability to carry out vital functions such as metabolism, growth, reproduction, responsiveness, and adaptability. Death, Cell
D054325 vpr Gene Products, Human Immunodeficiency Virus Proteins encoded by the VPR GENES of the HUMAN IMMUNODEFICIENCY VIRUS. HIV vpr Gene Product,Viral Protein R, HIV,vpr Protein, Human Immunodeficiency Virus

Related Publications

X J Yao, and A J Mouland, and R A Subbramanian, and J Forget, and N Rougeau, and D Bergeron, and E A Cohen
October 2000, Journal of virology,
X J Yao, and A J Mouland, and R A Subbramanian, and J Forget, and N Rougeau, and D Bergeron, and E A Cohen
July 1997, Journal of virology,
X J Yao, and A J Mouland, and R A Subbramanian, and J Forget, and N Rougeau, and D Bergeron, and E A Cohen
September 2007, Journal of virology,
X J Yao, and A J Mouland, and R A Subbramanian, and J Forget, and N Rougeau, and D Bergeron, and E A Cohen
October 1994, The Journal of general virology,
X J Yao, and A J Mouland, and R A Subbramanian, and J Forget, and N Rougeau, and D Bergeron, and E A Cohen
July 2005, Journal of virology,
X J Yao, and A J Mouland, and R A Subbramanian, and J Forget, and N Rougeau, and D Bergeron, and E A Cohen
April 2000, Journal of virology,
X J Yao, and A J Mouland, and R A Subbramanian, and J Forget, and N Rougeau, and D Bergeron, and E A Cohen
June 1991, The Journal of biological chemistry,
X J Yao, and A J Mouland, and R A Subbramanian, and J Forget, and N Rougeau, and D Bergeron, and E A Cohen
November 2013, Journal of neuroinflammation,
X J Yao, and A J Mouland, and R A Subbramanian, and J Forget, and N Rougeau, and D Bergeron, and E A Cohen
August 1998, Biochemical pharmacology,
X J Yao, and A J Mouland, and R A Subbramanian, and J Forget, and N Rougeau, and D Bergeron, and E A Cohen
October 1995, Journal of virology,
Copied contents to your clipboard!